(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 381.51%81.14M | 253.35%27.49M | 1,243.17%79.62M | 992.84%58.2M | -3,023.06%-84.23M | -1,553.70%-28.82M | -466.65%-17.92M | -936.46%-6.97M | -466.29%-6.52M | -201.68%-2.7M |
Net income from continuing operations | -87.91%27.37M | 2,186.72%284.63M | 1,209.69%96.29M | -99.77%-6.84M | -172.90%-1.53M | 6,317.97%226.33M | 79.46%-13.64M | -71.62%-8.68M | -377.63%-3.43M | 103.42%2.1M |
Operating gains losses | 10.30%889K | 111.81%187K | -299.48%-768K | 183.46%1.11M | 2.15%-1M | 112.11%806K | -102.56%-1.58M | -75.71%385K | -22.03%-1.32M | -101.69%-1.03M |
Depreciation and amortization | 42,020.35%47.6M | 338,634.21%128.72M | 174,205.56%31.38M | 785,616.67%47.14M | 834,766.67%50.09M | 1,312.50%113K | -79.79%38K | -89.22%18K | -14.29%6K | -14.29%6K |
Asset impairment expenditure | ---7.13M | --12.36M | --6.16M | ---3.77M | --9.98M | --0 | --0 | --0 | --0 | --0 |
Remuneration paid in stock | ---355K | --477K | --559K | --0 | ---82K | --0 | --0 | --0 | --0 | --0 |
Remuneration paid in stock | -7.52%529K | 376.63%1.98M | 390.05%936K | 349.12%256K | 296.30%214K | 406.19%572K | 68.70%415K | 63.25%191K | -48.18%57K | -43.16%54K |
Deferred tax | ---- | ---- | ---- | ---7.71M | ---19.03M | ---- | ---- | ---- | --0 | --0 |
Other non cashItems | 102.60%6.21M | -13,394.61%-222.66M | -3,315.37%-60.87M | 7,338.10%19.76M | 633.52%18.73M | -99,346.89%-239.19M | -303.96%-1.65M | -16.24%1.89M | 78.21%-273K | -1,600.43%-3.51M |
Change In working capital | 134.55%6.03M | -3,497.74%-54.04M | 13,326.19%102.5M | 629.78%8.25M | -43,603.09%-141.6M | -1,612.03%-17.46M | -3,959.46%-1.5M | -403.92%-775K | -850.00%-1.56M | 13.60%-324K |
-Change in other working capital | ---- | ---- | ---- | 629.78%8.25M | -43,603.09%-141.6M | ---- | ---- | ---- | ---1.56M | ---324K |
Tax refund paid | --0 | ---124.17M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 381.51%81.14M | 253.35%27.49M | 1,243.17%79.62M | 992.84%58.2M | -3,023.06%-84.23M | -1,553.70%-28.82M | -466.65%-17.92M | -936.46%-6.97M | -466.29%-6.52M | -201.68%-2.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -112.02%-28.41M | 896.44%130.35M | -105.68%-18.64M | -5,808.33%-36.87M | -553.19%-47.94M | 35,621.75%236.48M | -216.47%-16.37M | -302,233.33%-9.06M | -264.64%-624K | -152.49%-7.34M |
Capital expenditure reported | -691.44%-30.79M | -257,539.53%-110.79M | -350,177.78%-31.53M | -152,904.17%-36.72M | -552,014.29%-38.65M | ---3.89M | ---43K | ---9K | ---24K | -250.00%-7K |
Net business purchase and sale | --0 | 6,005.68%238.06M | --6M | --0 | --0 | --238.06M | ---4.03M | --0 | --0 | -128.07%-4.03M |
Net investment purchase and sale | ---- | ---- | ---- | 16.21%-2.94M | --0 | ---- | ---- | ---- | ---3.5M | ---4.2M |
Net other investing changes | 2.73%2.37M | 125.00%3.07M | 176.87%12.88M | -3.96%2.79M | -1,135.19%-9.3M | 247.37%2.31M | -4,469.52%-12.29M | -16.81%-16.76M | 615.27%2.9M | 341.40%898K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -112.02%-28.41M | 896.44%130.35M | -105.68%-18.64M | -5,808.33%-36.87M | -553.19%-47.94M | 35,621.75%236.48M | -216.47%-16.37M | -302,233.33%-9.06M | -264.64%-624K | -152.49%-7.34M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -123.60%-9.95M | -475.39%-41.8M | -343.50%-27.11M | -29.7M | -27.09M | 42.16M | 39,867.86%11.14M | 11.14M | 0 | 0 |
Net issuance payments of debt | -125.65%-9.01M | -491.52%-42.64M | -358.48%-28.15M | ---29.7M | ---27.35M | --35.13M | 38,992.86%10.89M | --10.89M | --0 | --0 |
Net common stock issuance | --0 | --6.85M | ---- | ---- | ---- | --6.85M | --0 | ---- | ---- | ---- |
Cash dividends paid | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | 78.74%311K | 305.71%994K | 130.61%565K | --0 | --255K | --174K | --245K | --245K | --0 | --0 |
Interest paid (cash flow from financing activities) | ---- | ---3.14M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net other financing activities | ---1.25M | ---3.88M | ---3.25M | ---- | ---2K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -123.60%-9.95M | -475.39%-41.8M | -343.50%-27.11M | ---29.7M | ---27.09M | --42.16M | 39,867.86%11.14M | --11.14M | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | 664.25%133.87M | -57.10%17.52M | 348.14%100M | 263.74%108.08M | 575.18%268.55M | -57.10%17.52M | 35.44%40.83M | -46.46%22.32M | -30.29%29.71M | 35.36%39.78M |
Current changes in cash | -82.87%42.78M | 601.13%116.03M | 791.97%33.87M | -17.28%-8.38M | -1,486.80%-159.27M | 23,209.07%249.81M | -313.18%-23.15M | -631.54%-4.89M | -825.13%-7.14M | -176.68%-10.04M |
Effect of exchange rate changes | -124.63%-302K | 304.49%319K | -101.05%-1K | 217.19%300K | -4,724.00%-1.21M | 3,986.67%1.23M | 12.36%-156K | 150.53%95K | -49.71%-256K | -116.45%-25K |
End cash Position | -34.33%176.35M | 664.25%133.87M | 664.25%133.87M | 348.14%100M | 263.74%108.08M | 575.18%268.55M | -57.10%17.52M | -57.10%17.52M | -46.46%22.32M | -30.29%29.71M |
Free cash from | 253.93%50.36M | -363.65%-83.3M | 789.66%48.1M | 428.25%21.47M | -4,444.27%-122.88M | -1,773.65%-32.71M | -461.44%-17.97M | -925.59%-6.97M | -455.35%-6.54M | -201.79%-2.7M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.